Literature DB >> 6595610

Second nonocular tumors in retinoblastoma survivors. Are they radiation-induced?

D H Abramson, R M Ellsworth, F D Kitchin, G Tung.   

Abstract

A review of 693 patients with bilateral retinoblastoma and 18 patients with unilateral/germinal retinoblastoma was carried out to find the incidence, time, course and pattern of second nonocular tumors in retinoblastoma survivors. Of 688 patients who survived therapeutic radiation for retinoblastoma, 89 developed second tumors: 62 in the field of radiation and 27 out of the field. Of 23 patients who received no radiation, five developed second tumors: one in the field and four out of the field. The most common tumor found was a sarcoma both in and out of the field of radiation. The incidence of second tumors increases with time, although the mean latent period is 10.4 years. At 10 years, the incidence of second tumors is 20%, at 20 years, it is 50% and at 30 years, 90%. The incidence of tumors in patients treated without radiation and where tumors developed outside the field was 10% at 10 years, 30% at 20 years and 68% at 32 years. There was no relationship between incidence of tumors and dose of therapeutic radiation when analyzed with life tables. A second course of radiation therapy did not increase the incidence of second nonocular tumors.

Entities:  

Mesh:

Year:  1984        PMID: 6595610     DOI: 10.1016/s0161-6420(84)34127-6

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  55 in total

1.  New and recurrent tumor foci following local treatment as well as external beam radiation in eyes of patients with hereditary retinoblastoma.

Authors:  E P Messmer; W Sauerwein; T Heinrich; W Höpping; D Klueter-Reckmann; N Bornfeld; H Sack; M Förster; W Havers
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1990       Impact factor: 3.117

2.  Radiotherapy in ophthalmology : 2004 Jules Gonin lecture of the Retina Research Foundation.

Authors:  Leonidas Zografos
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2006-07       Impact factor: 3.117

3.  Amplification and characterization of the retinoblastoma gene VNTR by PCR.

Authors:  S J Scharf; A M Bowcock; G McClure; W Klitz; D W Yandell; H A Erlich
Journal:  Am J Hum Genet       Date:  1992-02       Impact factor: 11.025

4.  Application of intragenic DNA probes in prenatal screening for retinoblastoma gene carriers in the United Kingdom.

Authors:  Z O Onadim; C D Mitchell; P C Rutland; B G Buckle; M Jay; J L Hungerford; K Harper; J K Cowell
Journal:  Arch Dis Child       Date:  1990-07       Impact factor: 3.791

5.  Constitutional deletions predisposing to retinoblastoma.

Authors:  M Janson; E Kock; M Nordenskjöld
Journal:  Hum Genet       Date:  1990-06       Impact factor: 4.132

Review 6.  Role of the retinoblastoma gene in the initiation and progression of human cancer.

Authors:  W F Benedict; H J Xu; S X Hu; R Takahashi
Journal:  J Clin Invest       Date:  1990-04       Impact factor: 14.808

7.  Trilateral retinoblastoma in transgenic mice.

Authors:  J M O'Brien; D M Marcus; A S Niffenegger; R Bernards; J L Carpenter; J J Windle; P Mellon; D M Albert
Journal:  Trans Am Ophthalmol Soc       Date:  1989

Review 8.  Current treatment and management of retinoblastoma.

Authors:  Dan S Gombos; And Patricia Chevez-Barrios
Journal:  Curr Oncol Rep       Date:  2007-11       Impact factor: 5.075

9.  Second primary osteosarcoma with rosette-like structure in a patient with retinoblastoma.

Authors:  Kyoji Okada; Tadashi Hasegawa; Ukihide Tateishi; Eiji Itoi
Journal:  Virchows Arch       Date:  2004-07-28       Impact factor: 4.064

Review 10.  Osteosarcoma development and stem cell differentiation.

Authors:  Ni Tang; Wen-Xin Song; Jinyong Luo; Rex C Haydon; Tong-Chuan He
Journal:  Clin Orthop Relat Res       Date:  2008-06-18       Impact factor: 4.176

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.